Furthermore, we also observed a strong correlation between CRELD2 levels and those of the CAF marker S100A4, suggesting that CRELD2 may also be involved in establishing a tumor‐promoting CAF phenotype in cSCC. Here, S100A4 is linked to neoplasm.